Health
We’re impressed with health insurer Humana’s solid quarter and rosy outlook for next year
Club holding Humana (HUM) reported a mixed-but-solid third quarter before the opening bell Wednesday. Early optimism about 2023 also supported our bullish view on the health insurer’s stock. Revenue increased 9% year-over-year to $22.75 billion, slightly below estimates of $22.76 billion, and adjusted earnings-per-share increased 42% to $6.88, exceeding estimates of $6.28 per share. Aiding […]
Read More
2 takeaways from our daily meeting: Stocks await Fed decision, Club earnings recap
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. Fed decision ahead Quick takes on Club earnings 1. Fed decision ahead Stocks edged down Wednesday ahead of the Federal Reserve’s decision on interest rate increases, set for this afternoon. […]
Read More
Eli Lilly’s guidance cut is about the strong dollar, not weakening fundamentals, CEO says
Eli Lilly (LLY) CEO David Ricks on Tuesday expressed optimism around the drugmaker’s innovation pipeline Tuesday, a stance we share despite the Club holding’s cluttered quarterly report issued earlier in the day . “The underlying fundamentals of the business are really strong,” Ricks said in a CNBC interview with Jim Cramer. “Seventy percent of our […]
Read More
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. John Thys | AFP | Getty Images Pfizer CEO Albert Bourla laid out his plan Tuesday […]
Read More
Pfizer raises 2022 earnings guidance, beats third-quarter expectations
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022. Rodrigo Garrido | Reuters Pfizer on Tuesday raised its 2022 earnings guidance after booking a strong third quarter that beat Wall Street expectations. Pfizer now expects earnings per share […]
Read More
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company’s data shows
Pfizer’s vaccine against respiratory syncytial virus, or RSV, is highly effective at protecting newborns when the shot is given to the mothers late in their pregnancy, according to clinical trial data published Tuesday. RSV is a common respiratory virus that generally causes mild cold-like symptoms, but it can be dangerous for infants younger than 6 […]
Read More
Long Covid is affecting women more than men, national survey finds
A woman receives a dose of a vaccine against the coronavirus disease (COVID-19) at a sport stadium during the coronavirus disease pandemic, in Vina del Mar, Chile, April 22, 2021. Rodrigo Garrido | Reuters Long Covid is more common among women than men, according to federal data. More than 17% of women have had long […]
Read More
Omicron subvariants resistant to key antibody treatments are increasing every week in the U.S.
Two omicron subvariants that are resistant to key antibody treatments are on the rise in the U.S., according to data from the Centers for Disease Control and Prevention. The subvariants BQ.1 and BQ.1.1 now represent 27% of infections in the U.S., a significant jump from the week prior when they made up about 16% of […]
Read More
Multiple revenue misses in one of our winners convinced us to take profits and get out
We never like to sell on a down day. But after an iffy quarter, we decided to exit. Source
Read More
We’re exiting a drug stock for a nice gain and putting some of that money to work elsewhere
Traders work on the floor of the New York Stock Exchange (NYSE) on October 27, 2022 in New York City. Stocks continued their upward gains Thursday with the Dow rising nearly 400 points following a new GDP report that beat expectations. Spencer Platt | Getty Images Source
Read More